Aaron C. Spalding

1.6k total citations
41 papers, 1.3k citations indexed

About

Aaron C. Spalding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Aaron C. Spalding has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Aaron C. Spalding's work include Glioma Diagnosis and Treatment (10 papers), Advanced Radiotherapy Techniques (7 papers) and Brain Metastases and Treatment (6 papers). Aaron C. Spalding is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Advanced Radiotherapy Techniques (7 papers) and Brain Metastases and Treatment (6 papers). Aaron C. Spalding collaborates with scholars based in United States, Italy and Israel. Aaron C. Spalding's co-authors include Gary L. Johnson, Theodore S. Lawrence, Steven M. Anderson, Spencer B. Gibson, Ryan Oyer, Edgar Ben‐Josef, Steven P. Zielske, Alex C. Kim, Lisa B. E. Shields and Gary D. Hammer and has published in prestigious journals such as Molecular and Cellular Biology, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Aaron C. Spalding

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron C. Spalding United States 21 565 341 323 221 195 41 1.3k
Renee M. McGovern United States 22 693 1.2× 534 1.6× 304 0.9× 154 0.7× 140 0.7× 50 1.5k
Julia Mohr Germany 17 839 1.5× 533 1.6× 356 1.1× 159 0.7× 143 0.7× 27 1.9k
Frank Griscelli France 21 969 1.7× 361 1.1× 438 1.4× 116 0.5× 108 0.6× 73 1.6k
Elias A. Castilla United States 19 768 1.4× 306 0.9× 396 1.2× 368 1.7× 263 1.3× 27 1.5k
Alexander von Werder Germany 14 540 1.0× 364 1.1× 171 0.5× 103 0.5× 178 0.9× 33 1.1k
Hans Kreipe Germany 16 323 0.6× 330 1.0× 246 0.8× 177 0.8× 153 0.8× 67 1.0k
Jeena Joseph India 17 722 1.3× 864 2.5× 373 1.2× 308 1.4× 155 0.8× 41 1.8k
Stephen J. Elliman Ireland 14 416 0.7× 364 1.1× 129 0.4× 146 0.7× 225 1.2× 26 1.1k
Christopher C. Porter United States 24 984 1.7× 497 1.5× 205 0.6× 158 0.7× 72 0.4× 83 1.8k
Shweta Joshi United States 23 655 1.2× 382 1.1× 239 0.7× 119 0.5× 74 0.4× 48 1.5k

Countries citing papers authored by Aaron C. Spalding

Since Specialization
Citations

This map shows the geographic impact of Aaron C. Spalding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron C. Spalding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron C. Spalding more than expected).

Fields of papers citing papers by Aaron C. Spalding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron C. Spalding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron C. Spalding. The network helps show where Aaron C. Spalding may publish in the future.

Co-authorship network of co-authors of Aaron C. Spalding

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron C. Spalding. A scholar is included among the top collaborators of Aaron C. Spalding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron C. Spalding. Aaron C. Spalding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Christopher B., Wei Xue, Abha A. Gupta, et al.. (2025). Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children’s Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 123(1). 54–62.
2.
Shields, Lisa B. E., et al.. (2025). Ventriculoperitoneal Shunt and Endoscopic Third Ventriculostomy for Hydrocephalus in Adult Patients With Brain Metastases. Cureus. 17(1). e77707–e77707. 1 indexed citations
3.
Shields, Lisa B. E., et al.. (2024). Frameless image-guided linear accelerator (LINAC) stereotactic radiosurgery for medically refractory trigeminal neuralgia: Clinical outcomes in 116 patients. Surgical Neurology International. 15. 181–181. 1 indexed citations
4.
Spalding, Aaron C., et al.. (2018). Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib. Experimental Hematology and Oncology. 7(1). 20–20. 5 indexed citations
5.
Burton, Eric, Beatrice Ugiliweneza, Murali Kolikonda, et al.. (2017). A Regional Multicenter Retrospective Analysis of Patients with Primary Central Nervous System Lymphoma Diagnosed from 2000-2012: Treatment Patterns and Clinical Outcomes. Cureus. 9(7). e1512–e1512. 8 indexed citations
6.
Shields, Lisa B. E., Brent J. Shelton, Andrew Shearer, et al.. (2015). Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients. Radiation Oncology. 10(1). 222–222. 62 indexed citations
7.
Rogers, Leland, Arie Perry, Stephanie L. Pugh, et al.. (2015). Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncology. 18(4). 565–574. 88 indexed citations
8.
Shields, Lisa B. E., et al.. (2015). Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study. Radiation Oncology. 10(1). 193–193. 6 indexed citations
9.
Shields, Lisa B. E., et al.. (2011). Tumor histology and location predict deep nuclei toxicity: Implications for late effects from focal brain irradiation. Medical dosimetry. 37(3). 276–279. 2 indexed citations
10.
Watson, Richard, Aaron C. Spalding, Steven P. Zielske, et al.. (2010). GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer. Neoplasia. 12(5). 357–365. 42 indexed citations
11.
Lee, Cheong, Aaron C. Spalding, Edgar Ben‐Josef, Lidong Wang, & Diane M. Simeone. (2010). In Vivo Bioluminescent Imaging of Irradiated Orthotopic Pancreatic Cancer Xenografts in Nonobese Diabetic-Severe Combined Immunodeficient Mice: A Novel Met Targeting and Assaying Efficacy of Ionizing Radiation. Translational Oncology. 3(3). 153–159. 21 indexed citations
12.
Zeitlin, Benjamin D., Zhaocheng Zhang, Kristy A. Warner, et al.. (2009). TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis. Molecular Cancer Therapeutics. 8(4). 893–903. 38 indexed citations
13.
Murphy, James D., et al.. (2009). Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature. Clinical Cancer Research. 15(2). 589–596. 40 indexed citations
14.
Spalding, Aaron C., et al.. (2009). The Metabolic Syndrome: A Modern Plague Spread by Modern Technology. Journal of Clinical Hypertension. 11(12). 755–760. 20 indexed citations
15.
Warner, Kristy A., Marta Miyazawa, Mabel Mariela Rodríguez Cordeiro, et al.. (2008). Endothelial Cells Enhance Tumor Cell Invasion through a Crosstalk Mediated by CXC Chemokine Signaling. Neoplasia. 10(2). 131–139. 62 indexed citations
16.
Spalding, Aaron C., Benjamin D. Zeitlin, Kari Wilder-Romans, et al.. (2008). Enzastaurin, an inhibitor of PKCβ, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells. Translational Oncology. 1(4). 195–IN1. 13 indexed citations
17.
Spalding, Aaron C., Richard Watson, Mary E. Davis, et al.. (2007). Inhibition of Protein Kinase Cβ by Enzastaurin Enhances Radiation Cytotoxicity in Pancreatic Cancer. Clinical Cancer Research. 13(22). 6827–6833. 19 indexed citations
18.
Spalding, Aaron C., Kyung‐Wook Jee, K.A. Vineberg, et al.. (2007). Potential for dose‐escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD‐based cost functions. Medical Physics. 34(2). 521–529. 36 indexed citations
19.
Spalding, Aaron C., Robert M. Jotte, Robert I. Scheinman, et al.. (2002). TRAIL and inhibitors of apoptosis are opposing determinants for NF-κB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene. 21(2). 260–271. 30 indexed citations
20.
Clarke, Penny, et al.. (2001). Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection. Oncogene. 20(47). 6910–6919. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026